1. Improve individual clinicians proficiency in the diagnosis and management of MH problems;
2. Strengthen cooperation and collaboration by: a. developing a common language by using a common clinical tool- the mhGAP-IG; b. exploring models of ongoing and future knowledge exchange and interactions about clinical realities.
3. Compare and confront different perspectives and different models of healthcare organization;
4. Help with clinical practices to better enable the integration of MH interventions.
- Describe the characteristics of influenza viruses, and the disease they cause
- List the objectives of public health surveillance and influenza surveillance
- Review the common types of surveillance and the types used for influenza surveillance
- Understand the need to intensify SARI surveillance
- Discuss how influenza surveillance data are used
- Understand the case definition for severe acute respiratory infection (SARI) and the principle etiologic agents of SARI
- Compare SARI case definition to that of influenza-like illness (ILI)
- Understand the methods used to identify SARI cases, types of clinical samples to collect and what data are to be reported
- Describe the surveillance steps from case identification to collection of epidemiologic information
- Organize, compile and assess the data collected
- Understand the uses of absolute and relative measures
- Describe the seven key SARI indicators
- Interpret the recommended outputs for SARI indicators
- Construct tables and graphs to illustrate proportions and distributions
- Interpret tables and figures to analyze trends
- Understand the roles and responsibilities for intensified national SARI surveillance
- Describe the information flow related to intensified national SARI surveillance
- Describe the characteristics of influenza viruses, and the disease they cause
- List the objectives of public health surveillance
- Explain why laboratory data are important for influenza surveillance
- Interpret measures used to determine the burden of disease
- Understand frequency measures used in statistical reporting for influenza surveillance
- Understand the uses of absolute and relative measures
- Identify the five key measures to include in an influenza weekly report
- List the characteristics of well-constructed tables and graphs
- Display in graphical and tabular format, weekly data
- List the key characteristics of oral and written presentations
Upon finishing the course, participants should be able to:
- Design risk communication strategies using a risk map to analyze the local context and systematically incorporating lessons learned.
- Understand the importance of risk perceptions and other relevant risk communication concepts and incorporate these in the design of effective strategies and in adjustments according to the local context.
- Identify monitoring and evaluation activities appropriate for the interventions and communication processes in the risk communication strategy.
- Understand the important steps for communicating effectively with the internal and external target audiences, including partners, stakeholders, the media, online social networks, health personnel and the public.
- Recognize the structural elements of PHC renewal based on a public health framework, as well as necessary competencies for their attainment;
- Participate in a review process on the progress and challenges in the practice of PHC renewal in the national and international context;
- Design an intervention proposal for PHC renewal within the scope of the participants workplace.
- Identify the epidemiological and clinical characteristics of influenza, focusing on influenza A(H1N1);
- Recognize and implement critical aspects of health services preparedness;
- Identify priority actions for preventing transmission and caring for cases of pandemic influenza;
- Know the different protective measures for health care workers and the public;
- Analyze information on the behavior and management of the epidemic;
- Provide a source of recent news and developments on the epidemics behavior.
- Ensure smooth introduction of the rotavirus vaccine;
- Assist with planning for program sustainability;
- Promote further strengthening of existing immunization programs.